Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
11 October 2018 | Story UFS | Photo Zama Feni
UFS launch student business incubator project
Rector and Vice-Chancellor Francis Peterson cutting the ribbon as the office of Student Business Incubator Project was officially opened last Friday.
The University of Free State has recently launched a Student Business Incubator Project that will provide impetus to students with business ideas.

The initiative, which is under the management of the Directorate for Research and Development (DRD) was conceived a few years ago with objective of untapping the entrepreneurial potential of students. 

And it was on Friday last week that all the energy and efforts that were directed towards the planning of this project culminated into the official launch and opening of the offices where the students will conduct their business operations.

Generate new business ideas

Delivering a brief address at the launch, Rector and Vice-Chancellor, Prof Francis Petersen encouraged students to generate new business ideas that would make them job creators at the end of the day. 

“As a university, we should disseminate our output to society through research, education and technology transfer. The Incubator Project is a good initiative and I would like to see it growing so that more students can benefit from a facility such as this,” he said. 
Professor Petersen encouraged the student innovators to engage society so that they can make quality of life better through new knowledge.

“You must continue to incubate ideas and develop them,” he said adding that one of the great things that a university is measured about is the employability of its graduates.

Business ideas awarded 
On the previous day, DRD hosted a pitching competition for the business ideas that students were invited to submit.

Assistant Research Officer and Project Manager, Ayanda Makhanya said they were excited about the outcome of their call to students as they received an overall total of 60 ideas.

“We screened all the inputs and came up with 14 ideas. We will now be working with these students to provide the necessary support,” she said.

The winner in the pitching competition was an LLB student Mannini Setai whose idea was the production of eco-friendly bricks.

The office are located near the UFS Sasol Library and has computers and a big flat screen.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept